Stocks and InvestingStocks and Investing
Tue, March 1, 2022
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022

Chris Howerton Downgraded (VNDA) to Hold and Decreased Target to $12 on, Feb 25th, 2022


Published on 2024-10-27 19:51:35 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Downgraded "Vanda Pharmaceuticals Inc." (VNDA) to Hold and Decreased Target from $24 to $12 on, Feb 25th, 2022.

Chris, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30